Update on the Use of Linezolid
- 1 October 2004
- journal article
- review article
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 23 (10) , 955-956
- https://doi.org/10.1097/01.inf.0000142502.13252.20
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Oxazolidinones: activity, mode of action, and mechanism of resistanceInternational Journal of Antimicrobial Agents, 2004
- Antibacterial susceptibility of a vancomycin-resistant Staphylococcus aureus strain isolated at the Hershey Medical CenterJournal of Antimicrobial Chemotherapy, 2003
- Linezolid pharmacokinetics in pediatric patients: an overviewThe Pediatric Infectious Disease Journal, 2003
- Linezolid Resistance since 2001: SENTRY Antimicrobial Surveillance ProgramAnnals of Pharmacotherapy, 2003
- Linezolid in vitro: mechanism and antibacterial spectrumJournal of Antimicrobial Chemotherapy, 2003
- Linezolid for the Treatment of Multidrug‐Resistant, Gram‐Positive Infections: Experience from a Compassionate‐Use ProgramClinical Infectious Diseases, 2003
- Linezolid penetration into osteo-articular tissuesJournal of Antimicrobial Chemotherapy, 2002
- Oxazolidinone antibioticsThe Lancet, 2001
- Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox® Antimicrobial Potency Study (ZAPS) in the United StatesDiagnostic Microbiology and Infectious Disease, 2001
- Comparative In Vitro and Bactericidal Activity of Oxazolidinone Antibiotics Against Multidrug-Resistant EnterococciDiagnostic Microbiology and Infectious Disease, 1998